TrianglePUBLICATIONS · 15581974
A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Gynecol Oncol
- Publication date
- 2004 Dec
- First author
- Berkenblit A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Berkenblit A
- type
- Author
- name
- Seiden MV
- type
- Author
- name
- Matulonis UA
- type
- Author
- name
- Penson RT
- type
- Author
- name
- Krasner CN
- type
- Author
- name
- Roche M
- type
- Author
- name
- Mezzetti L
- type
- Author
- name
- Atkinson T
- type
- Author
- name
- Cannistra SA
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Berkenblit A
- type
- Author
- name
- Seiden MV
- type
- Author
- name
- Matulonis UA
- type
- Author
- name
- Penson RT
- type
- Author
- name
- Krasner CN
- type
- Author
- name
- Roche M
- type
- Author
- name
- Mezzetti L
- type
- Author
- name
- Atkinson T
- type
- Author
- name
- Cannistra SA
- type
- Author
- bibliography ids
- nci-bib-21e167151d5d0e1b145f4bdf
- book metadata
- content sha256
- efe336e8afbbe1ab66eec89898221a2aca0fbc75644e651e0d9ae867390b2873
- document type
- citation
- dois
- 10.1016/j.ygyno.2004.08.028
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:15581974
- immutable id
- pubmed:15581974@efe336e8afbbe1ab66eec89898221a2aca0fbc75644e651e0d9ae867390b2873
- journal
- abbreviation
- Gynecol Oncol
- issn electronic
- Source null
- issn print
- 0090-8258
- issue
- 3
- name
- Gynecologic oncology
- nlm unique id
- 0365304
- pages
- 624-31
- volume
- 95
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 15581974
- provenance
- batch id
- 97b9e848a139d5f8d462
- provider
- NCBI PubMed ESummary
- record sha256
- c76222e46e53fee2f1ab6af164cabb69a1ae205a9d1c2c4b7674a32608c6ee72
- response sha256
- a316b1e9f1b120fc4a41adaaf2b205cc00afcf76d9a093a7cfa9ed2743d05be8
- retrieved at
- 2026-09-09T23:45:57.930512+00:00
- publication date
- display
- 2004 Dec
- precision
- month
- year
- 2004
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer.
Preserved source evidence · Not medical advice